UnitedHealth Group (NYSE:UNH) Price Target Cut to $450.00 by Analysts at KeyCorp

UnitedHealth Group (NYSE:UNH) had its target price reduced by research analysts at KeyCorp from $575.00 to $450.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. KeyCorp’s target price points to a potential upside of 64.26% from the company’s current price.

A number of other brokerages have also issued reports on UNH. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays cut their price objective on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Oppenheimer cut their price objective on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, April 21st. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Six analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $508.38.

UnitedHealth Group Stock Down 11.1%

UNH opened at $273.96 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $248.52 billion, a P/E ratio of 17.67, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 52 week low of $248.88 and a 52 week high of $630.73. The business’s fifty day simple moving average is $474.72 and its 200 day simple moving average is $515.82.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business earned $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Institutional Trading of UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC increased its stake in UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors increased its stake in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Finally, Norges Bank purchased a new position in UnitedHealth Group in the 4th quarter worth about $6,375,744,000. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.